TRGV5
T cell receptor gamma variable 5
Also known as: TCRGV5, TRGV5_HUMAN, V1S5
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A0A0B4J1U4
- Gene
- TRGV5
- Ensembl
- ENSG00000211697
- Chromosome
- 7
- Canonical length
- 118 aa
- Protein class
- Predicted intracellular proteins, T-cell receptor genes
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to be involved in adaptive immune response and innate immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. Predicted to be active in external side of plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
118 residues, UniProt reviewed canonical sequence.
>A0A0B4J1U4|TRGV5
1 MRWALLVLLA FLSPASQKSS NLEGGTKSVT RPTRSSAEIT CDLTVINAFY IHWYLHQEGK
61 APQRLLYYDV SNSKDVLESG LSPGKYYTHT PRRWSWILIL RNLIENDSGV YYCATWDRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRGV5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 5.5 nTPM
Expression across tissuesHPA
Tissue
- thymus: 5.5 nTPM
- tonsil: 4.4 nTPM
- lymph node: 3.4 nTPM
- spleen: 3.4 nTPM
- bone marrow: 2.2 nTPM
- gallbladder: 1.8 nTPM
Single-cell type
- t-cells: 3.5 nCPM
- thymocytes: 1.7 nCPM
- platelets: 1.4 nCPM
- cdc: 1.2 nCPM
- monocytes: 0.9 nCPM
- plasma cells: 0.6 nCPM
Immune cell
- gdT-cell: 25 nTPM
- memory CD8 T-cell: 22 nTPM
- MAIT T-cell: 20 nTPM
- naive CD8 T-cell: 9.6 nTPM
- NK-cell: 8.2 nTPM
- plasmacytoid DC: 7 nTPM
Brain region
- midbrain: 1.5 nTPM
- medulla oblongata: 0.8 nTPM
- thalamus: 0.8 nTPM
- pons: 0.7 nTPM
- choroid plexus: 0.4 nTPM
- spinal cord: 0.4 nTPM
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRGV5 as an antibody target. Whether an autoantibody or antibody against TRGV5 could matter depends on whether native TRGV5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRGV5 is annotated at the cell surface, where native TRGV5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRGV5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...